Vitamin D deficiency may lead to an early death

Publicly released:
Australia; SA

An Australian study, using data from over 300,000 people, has found that vitamin D deficiency may be causing premature death. The study involved a technique called ‘Mendelian Randomisation’ - which uses genetics to allow scientists to determine whether one thing causes another, rather than them just being linked. The study found that the risk of death decreased steeply with increasing Vitamin D levels, up to the recommended levels (50 nmol/L) and the biggest effect was in people with severe deficiency (less than 25nmol/L) The authors say more research is needed to identify strategies that reduce the premature risk for death associated with low vitamin D levels.

Media release

From: American College of Physicians

It’s the vitamin that we get from the sun, yet despite its ample availability, one in three Australian adults still suffer from mild, moderate or severe vitamin D deficiency.

Now, new research from the University of South Australia gives strong evidence that vitamin D deficiency is associated with premature death, prompting calls for people to follow healthy vitamin D level guidelines.

Published in Annals of Internal Medicine, the study found that the more severe the vitamin D deficiency, the greater the risk of mortality.

Vitamin D is an important nutrient that helps maintain good health and keep our bones and muscles strong and healthy.

First author and UniSA PhD candidate, Josh Sutherland, says while vitamin D has been connected with mortality, it has been challenging to establish causal effects.

“While severe vitamin D deficiency is rarer in Australia than elsewhere in the world, it can still affect those who have health vulnerabilities, the elderly, and those who do not acquire enough vitamin D from healthy sun exposure and dietary sources,” Sutherland says.

“Our study provides strong evidence for the connection between low levels of vitamin D and mortality, and this is the first study of its kind to also include respiratory disease related mortality as an outcome.

“We used a new genetic method to explore and affirm the non-linear relationships that we’ve seen in observational settings, and through this we’ve been able give strong evidence for the connection between low vitamin D status and premature death.

“Vitamin D deficiency has been connected with mortality, but as clinical trials have often failed to recruit people with low vitamin D levels – or have been prohibited from including vitamin deficient participants – it’s been challenging to establish causal relationships.”

The Mendelian randomization study evaluated 307,601 records from the UK Biobank. Low levels of vitamin D were noted as less than <25 nmol/L with the average concentration found to be 45.2 nmol/L. Over a 14-year follow up period, researchers found that the risk for death significantly decreased with increased vitamin D concentrations, with the strongest effects seen among those with severe deficiencies.

Senior investigator and Director of UniSA’s Australian Centre for Precision HealthProfessor Elina Hyppönen, says more research is now needed to establish effective public health strategies that can help achieve national guidelines and reduce the risk of premature death associated with low vitamin D levels.

“The take-home message here is simple – the key is in the prevention. It is not good enough to think about vitamin D deficiency when already facing life-challenging situations, when early action could make all the difference,” Prof Hyppönen says.

“It is very important to continue public health efforts to ensure the vulnerable and elderly maintain sufficient vitamin D levels throughout the year.”

Notes for editors:

·         UK Biobank is a large-scale biomedical database and research resource containing anonymised genetic, lifestyle and health information from half a million UK participants. UK Biobank’s database, which includes blood samples, heart and brain scans and genetic data of the volunteer participants, is globally accessible to approved researchers who are undertaking health-related research that’s in the public interest.

·         UK Biobank’s resource was opened for research use in April 2012. Since then 30,000 researchers from 100 countries have been approved to use it and more than 5,000 peer-reviewed papers that used the resource have now been published.

·         More about UK Biobank: http://www.ukbiobank.ac.uk

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research American College of Physicians, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference:
Annals of Internal Medicine
Research:Paper
Organisation/s: University of South Australia, South Australian Health and Medical Research Institute (SAHMRI)
Funder: National Health and Medical Research Council (NHMRC)
Media Contact/s
Contact details are only visible to registered journalists.